The PAI-1 level is higher in gastric cancer tissue than in normal tissue, and its overexpression leads to poor survival in gastric cancer patients via increasing tumorigenicity and inhibition of cancer cells apoptosis82–84, as was confirmed by GEPIA. This evidence concerns the gene SERPINE1 and gastric cancer.